 37 PM / Updated 8 minutes ago BRIEF-Spero Therapeutics Appoints David Melnick As Chief Medical Officer Reuters Staff 
Jan 4 (Reuters) - Spero Therapeutics Inc: 
* SPERO THERAPEUTICS APPOINTS DAVID MELNICK, M.D., AS CHIEF MEDICAL OFFICER 
* SPERO THERAPEUTICS INC - ‍PRIOR TO JOINING CO, MELNICK SERVED AS VICE PRESIDENT OF CLINICAL DEVELOPMENT FOR ANTI-INFECTIVES AT ALLERGAN SINCE 2015​ Source text for Eikon: Further company coverage: